Zilo M Kid 2.5mg/4mg ODT is often recommended for pediatric patients to alleviate various allergy symptoms, which may include a runny nose, sneezing, itching, swelling, nasal congestion, and watery eyes. Additionally, it can be effective for managing asthma symptoms as well as skin-related allergies. It is important to administer this medication to your child consistently, either before or after meals, in accordance with the prescribed dosage and schedule. For asthma management, it is advisable to provide this medication in the evening or at least two hours prior to any physical exertion. When addressing allergy symptoms, administering in the morning or evening is typically suggested, depending on when symptoms first appear. If your child experiences both conditions, evening administration is preferable. Should your child vomit within half an hour of taking the medication, you may repeat the dose unless it is close to the time for the next scheduled dose. Your child may begin to notice an improvement in symptoms after a few doses, but it is crucial to continue the full course as prescribed to optimize effectiveness. Abruptly discontinuing this medication may exacerbate your child’s symptoms. Minor, temporary side effects such as vomiting, diarrhea, nausea, dizziness, dry mouth, rash, and headaches can occur but usually resolve as the body adjusts to the medication. If these reactions persist or cause discomfort, seek guidance from your child’s healthcare provider. It is essential to inform the doctor about any other medications your child is taking, as well as to provide a comprehensive medical history, including past allergy incidents, heart conditions, blood disorders, vascular issues, congenital anomalies, airway obstructions, lung conditions, skin disorders, and any kidney or liver problems. This information is vital for determining the appropriate dosage and overall treatment plan for your child.
-15%

XYZAL M KID 2.5/4MG
Original price was: ₹102.70.₹87.60Current price is: ₹87.60.
Reviews
There are no reviews yet.